Whistleblower Qui Tam Lawsuit Leads to Recovery of $39 Million for Children’s Fluoride Multivitamins
18. Dezember 2015 16:43 ET
|
McCabe Rabin, P.A.
WEST PALM BEACH, Fla., Dec. 18, 2015 (GLOBE NEWSWIRE) -- Pharmaceutical giant Endo Pharmaceuticals Inc., and seven of its subsidiaries, will pay $39 million to settle a whistleblower qui tam...